BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
暂无分享，去创建一个
Benjamin J Kim | T. Aleman | G. Linette | P. Gimotty | J. Sosman | A. Kossenkov | R. Mick | L. Schuchter | R. Amaravadi | S. Chandra | A. Huang | L. Hernandez-Aya | T. Mitchell | A. Silk | J. Mehnert | N. Frey | G. Karakousis | G. Ansstas | Lydia R Giles | Alexander C. Huang | Sheryl Mitnick | R. Groisberg | M. Carberry | Benjamin J. Kim | L. Giles | Mary Carberry